60 minutes
Over the past decade, new biotech company creation has shifted away from investing in entrepreneurs to the venture creation model, where venture investors themselves assess an unmet medical need and create a company to address it. Yet, companies continue to spawn outside the venture creation model. Come hear experts discuss how they've raised money outside of the venture creation model through new sources of capital.


Paula Ragan - CEO, X4 Pharmaceuticals
Ramani Varanasi - Co-Founder, President & CEO,
Rosemary Reilly - Partner, WilmerHale
Todd Zion - President & CEO, Akston Biosciences Corporation
Name Audience
Business Track